These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 100975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 3. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP, Daumont A, Bouvier M, Lejeune E.
    Nouv Presse Med; 1978 Nov 25; 7(41):3753-6. PubMed ID: 733525
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 7. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M, Bozzi A, Telesca ML, Carrozzo M.
    Minerva Med; 1981 Apr 07; 72(14):865-8. PubMed ID: 7219796
    [Abstract] [Full Text] [Related]

  • 8. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 9. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A, Flores A, DeRose J, Wallach S.
    J Clin Endocrinol Metab; 1976 Mar 23; 42(3):459-63. PubMed ID: 1254686
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of Paget's disease with synthetic human calcitonin (author's transl)].
    Gerschpacher H, Schindler H.
    Wien Klin Wochenschr; 1980 Aug 01; 92(15):535-8. PubMed ID: 6933743
    [Abstract] [Full Text] [Related]

  • 11. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R, Kovarik J, Woloszczuk W, Plenk H, Willvonseder R, Böhler N, Seidl G, Höfer R.
    Aktuelle Gerontol; 1983 Jan 01; 13(1):10-4. PubMed ID: 6131616
    [Abstract] [Full Text] [Related]

  • 12. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec 01; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T, Fuss M, Brauman J, Orloff S, Bergans A, Corvilain J.
    Rev Rhum Mal Osteoartic; 1977 Jan 01; 44(1):59-66. PubMed ID: 319520
    [No Abstract] [Full Text] [Related]

  • 14. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G, Franchimont P, Gaspar S, Gysen P, Kanis JA.
    Ann Endocrinol (Paris); 1981 Jan 01; 42(3):265-75. PubMed ID: 7316460
    [Abstract] [Full Text] [Related]

  • 15. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG, Caldwell JG.
    J Clin Invest; 1972 Dec 01; 51(12):3133-41. PubMed ID: 4674398
    [Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S, Owen G.
    S Afr Med J; 1977 Jan 29; 51(5):133-7. PubMed ID: 850845
    [Abstract] [Full Text] [Related]

  • 17. [Biological exploration of Paget's disease].
    Eisinger J, Laponche AM, Roux H, Recordier AM.
    Rev Rhum Mal Osteoartic; 1976 Feb 29; 43(2):105-11. PubMed ID: 131366
    [Abstract] [Full Text] [Related]

  • 18. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 29; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 19. [Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)].
    Hobitz H.
    Wien Klin Wochenschr; 1982 Feb 05; 94(3):67-75. PubMed ID: 7043901
    [Abstract] [Full Text] [Related]

  • 20. [The treatment of Paget's disease of bone with human calcitonin (author's transl)].
    Burckhardt P.
    Schweiz Rundsch Med Prax; 1978 Jul 25; 67(30):1103-7. PubMed ID: 556449
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.